GREENVILLE, S.C. — A South Carolina research clinic is taking a primary role in the research of a drug that could attack Alzheimer’s disease.
Tribe Clinical Research in Greenville said they are in the midst of researching a drug that targets an abnormal protein that scientists link to the disease.
“I like to think of it as a clogged sink, so to speak. The treatments that are already FDA-approved today help with allowing some of the water to drain that really help with the symptoms of Alzheimer's. The drugs that we're studying today actually poke at the clog and help remove that clog bit by bit,” Jennifer Lehman said as an analogy for the drug.
Considering participating in a clinical trial but not sure what to expect?
You’re not alone. Many people are interested in research opportunities but hesitate because the process feels unfamiliar. The good news is that clinical trials are carefully designed with participant safety as the top priority, and every volunteer has the right to ask questions and make informed decisions.